Limitations of tissue microarrays in the evaluation of bcl-2 and P53 expression in whole mount derived prostate tissues

By Merseburger A.   Kuczyk M.   Moul J.   Sesterchenn I.   Jonas U.   Srivastava S.   Mostofi E.  

European Urology Supplements, Vol. 2, Iss. 1, 2003-02 ,pp. : 59-59

Elsevier

Access to resources Recommend Favorite

MDM2 mRNA Expression in the p53 Pathway May Predict the Potential of Invasion and Liver Metastasis in Colorectal Cancer

By Kondo Ito   Iida Satoru   Takagi Yoko   Sugihara Kenichi  

Diseases of the Colon & Rectum, Vol. 51, Iss. 9, 2008-09 ,pp. : 1395-1402

Springer Publishing Company

Access to resources Recommend Favorite

Recurrence of benign meningiomas: predictive value of proliferative index, BCL2, p53, hormonal receptors and HER2 expression

By Abdelzaher Eman  

British Journal of Neurosurgery, Vol. 25, Iss. 6, 2011-12 ,pp. : 707-713

Informa Healthcare

Access to resources Recommend Favorite

p53 and bcl-2 immunohistochemical alterations in prostate cancer treated with radiation therapy

By Huang A.   Gandour-Edwards R.   Rosenthal S.A.   Siders D.B.   Deitch A.D.   Devere White R.W.  

Urology, Vol. 51, Iss. 2, 1998-02 ,pp. : 346-351

Elsevier

Access to resources Recommend Favorite

HER-2/neu overexpression is an independent prognostic factor in colorectal cancer

By Park Dong   Kang Mun   Oh Suk   Kim Hong   Cho Yong   Sohn Chong   Jeon Woo   Kim Byung   Han Won   Kim Hungdai   Ryu Seung   Sepulveda Antonia  

International Journal of Colorectal Disease, Vol. 22, Iss. 5, 2007-05 ,pp. : 491-497

Springer Publishing Company

Access to resources Recommend Favorite